Atara Biotherapeutics, Inc.·4

Jan 2, 7:14 PM ET

MCGRATH JOHN 4

4 · Atara Biotherapeutics, Inc. · Filed Jan 2, 2018

Insider Transaction Report

Form 4
Period: 2017-12-29
MCGRATH JOHN
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2017-12-29$20.00/sh32,000$640,00096,654 total
Footnotes (1)
  • [F1]Transaction pursuant to Rule 10b5-1 Plan adopted July 6, 2016.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION